title: A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill.
authors.affiliation: Sociedad Española de Cardiología, Madrid, Spain. Electronic address: Jose.Ramon.Gonzalez.Juanatey@sergas.es.
authors.forename: José Ramón
authors.initials: JR
authors.lastname: González-Juanatey
authors.affiliation: Sociedad Española de Medicina Interna, Madrid, Spain.
authors.forename: José María
authors.initials: JM
authors.lastname: Mostaza
authors.affiliation: Sociedad Española de Medicina de Familia y Comunitaria, Barcelona, Spain.
authors.forename: José María
authors.initials: JM
authors.lastname: Lobos
authors.affiliation: Sociedad Española de Médicos Generales y de Familia, Madrid, Spain.
authors.forename: Benjamín
authors.initials: B
authors.lastname: Abarca
authors.affiliation: Sociedad Española de Médicos de Atención Primaria, Madrid, Spain.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Llisterri
mesh_terms: D006801:Humans; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D000069059:Atorvastatin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004338:Drug Combinations; D005060:Europe; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D055118:Medication Adherence; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D017257:Ramipril / Q000627:therapeutic use; D055502:Secondary Prevention; D013030:Spain; D003245:Consensus Statements as Topic
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin; D000069059:Atorvastatin; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D017257:Ramipril